Annual Report 2023

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2023 120 The United Laboratories International Holdings Limited Annual Report 2023 31. SHARE CAPITAL (Continued) Notes: (i) During the year ended 31 December 2022, the Company repurchased its own ordinary shares through the Stock Exchange as follows: Month of repurchase No. of ordinary shares of HK$0.01 each Price per share Aggregate consideration paid Highest Lowest HK$ HK$ HK$’000 January 3,324,000 4.60 4.38 14,744 March 3,068,000 4.10 3.95 12,274 April 5,524,000 4.10 4.00 22,618 September 4,000 3.20 3.20 13 October 544,000 3.20 3.17 1,736 RMB’000 Shown in the consolidated financial statements as: At 31 December 2022 42,044 (ii) 4,716,000 ordinary shares were repurchased during the year ended 31 December 2021 and have been cancelled during the year ended 31 December 2022. None of the Company’s subsidiaries purchased, sold or redeemed any of the Company’s listed securities during both years.